BioTrends is the leader in providing specialized, syndicated market research in clinically complex, small to mid-size pharmaceutical markets.
By extension of our syndicated publications, BioTrends partners with clients to provide custom research solutions that allow clients to intimately understand their markets and to make informed business decisions.
BioTrends provides an email subscription service for its news releases
Please click the link below to subscribe:
Subscribe Here
US NEPHROLOGISTS REPORT MANAGEMENT CHANGES IN KIDNEY DISEASE
Read more... Link
CIMZIA MATCHES SIMPONI ON KEY PERFORMANCE METRICS IN THE TREATMENT OF RA AND ACTEMRA UPTAKE CONTINUES, DESPITE NEED FOR LAB MONITORING
Read more... Link
EUROPEAN NEPHROLOGISTS REPORT ON SHIFTING PRACTICE PATTERNS FOR HYPERPHOSPHATEMIA AND RENAL ANEMIA
Read more... Link
NINETY PERCENT OF SURVEYED RHEUMATOLOGISTS INTEND TO PRESCRIBE BENLYSTA, THE FIRST NOVEL DRUG FOR THE TREATMENT OF LUPUS IN 50+ YEARS, IN THE FIRST YEAR OF LAUNCH
Read more... Link
RHEUMATOLOGISTS EXPRESS SIGNIFICANT INTEREST IN BENLYSTA, THE FIRST NOVEL DRUG FOR THE TREATMENT OF LUPUS IN DECADES
Read more... Link
